Search results
Results from the WOW.Com Content Network
Lobular carcinoma in situ (LCIS) is an uncommon condition in which abnormal cells form in the milk glands (lobules) in the breast. Lobular carcinoma in situ (LCIS) isn't cancer. But being diagnosed with LCIS indicates that you have an increased risk of developing breast cancer.
Lobular carcinoma in situ (LCIS) is a type of breast change that is sometimes seen when a breast biopsy is done. In LCIS, cells that look like cancer cells are growing in the lining of the milk-producing glands (lobules) of the breast, but they don’t invade through the wall of the lobules.
Lobular carcinoma in situ (LCIS) may be present in one or both breasts, but it usually isn't visible on a mammogram. The condition is most often diagnosed as an incidental finding when you have a biopsy done to evaluate some other area of concern in your breast.
Breast surgeon Melissa Camp, M.D., M.P.H., explains what you should know about lobular carcinoma in situ and how to work with your doctor to keep yourself safe and healthy. The phrase “in situ” means “in the original place.” LCIS is contained within the lobules of the breast.
Lobular carcinoma in situ (LCIS) is a rare breast condition. It causes abnormal cells in your lobules — the glands in your breasts that produce breast milk. LCIS isn’t breast cancer but it does increase the chance you’ll have breast cancer.
Lobular carcinoma in situ (LCIS) is a type of in-situ carcinoma of the breast. While DCIS is considered a pre-cancer, it is unclear whether LCIS is a pre-cancer or if it’s just a general risk factor for developing breast cancer.
What is lobular carcinoma in situ (LCIS)? When abnormal cells grow inside the breast lobules (small, round sacs that produce milk for breastfeeding), but have not spread to nearby tissue or beyond, the condition is called lobular carcinoma in situ (LCIS).